DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
150 hedge funds and large institutions have $345M invested in DIPLOMAT PHARMACY, INC. in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 37 closing their positions.
53% more call options, than puts
Call options by funds: $2.8M | Put options by funds: $1.83M
42% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 36
4% less funds holding
Funds holding: 157 → 150 (-7)
16% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 37
60% less capital invested
Capital invested by funds: $871M → $345M (-$526M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$48.5M |
| 2 |
AC
Armistice Capital
New York
|
+$31M |
| 3 |
Millennium Management
New York
|
+$9.59M |
| 4 |
D.E. Shaw & Co
New York
|
+$7.43M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$115M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$32M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$14.5M |
| 4 |
Bank of New York Mellon
New York
|
-$10.7M |
| 5 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$8.61M |
DPLO Hedge Fund Activity: Q1 2019 in Review
150 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2019, worth a combined $345M — down 60% from $871M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of DPLO and 31 opened new positions — a net loss of 6 holders — while 36 trimmed existing stakes and 51 added.
The largest buyer was Deerfield Management, adding an estimated $48.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $115M sold.
- 150 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2019, down from 157 in Q4 2018.
- Funds reported $345M of DIPLOMAT PHARMACY, INC. stock for Q1 2019, down 60% quarter-over-quarter.
- 31 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2019 and 37 closed out, a net change of -6 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2019 was Deerfield Management, an estimated $48.5M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q1 2019 was Janus Henderson Group, an estimated $115M sold.
Based on aggregated 13F filings for Q1 2019.